Sunnyvale, Calif., March 21, 2004 - Molecular Devices Corporation (Nasdaq: MDCC), today announced that it has entered into a definitive agreement to acquire Axon Instruments, Inc., (ASX:AXN.AX) for approximately U.S. $70 million in cash and approximately…
Read More